Recordati is a global pharmaceutical company, listed on the Italian stock exchange, with over 4,450 employees. The company develops and commercializes medicines to serve people living with common diseases, as well as those living with rare diseases, in around 150 countries. Committed to social and environmental responsibility, Recordati aims to make a positive impact worldwide. With a long history in life-enhancing and life-changing medicines, it continues to unlock the full potential of life. Headquartered in Milan, Italy, Recordati also actively engages in research and development, as well as industrial operations.